Table 3.
TOMM20 and MCT4 staining and clinicopathologic characteristics.
| Stroma MCT4 IHC | high | low | OR | CI | p-value |
|---|---|---|---|---|---|
| Tumor Associated Stroma Non Tumor Associated Stroma |
36 1 |
10 41 |
N/A* | N/A* | 0.0001 |
| High-risk PTC Low-risk PTC |
19 17 |
0 10 |
0.47 | (0.14,1.02) | 0.028 |
| Hashimoto's No Hashimoto's |
9 27 |
3 8 |
0.75 | (0.13,4.20) | 0.744 |
| Clinical Adenopathy No Clinical Adenopathy |
19 17 |
0 10 |
0.47 | (0.14,1.02) | 0.028 |
| MACIS Score <6 MACIS Score ≥6 |
25 11 |
10 0 |
0.45 | (0.00,0.79) | 0.003 |
| AGES ≤4 AGES >4 |
26 10 |
10 0 |
0.49 | (0.00,0.75) | 0.004 |
| AMES Low AMES High |
22 14 |
10 0 |
0.37 | (0.00,0.69) | 0.002 |
| ATA Low ATA Intermed / Hig |
15 21 |
10 0 |
0.49 | (0.00,0.81) | 0.001 |
| Age <40 Age ≥40 |
9 27 |
2 8 |
0.75 | (0.13,4.20) | 0.744 |
| (+) PNI (−)PNI |
5 31 |
0 10 |
0.66 | (0.00,0.83) | 0.004 |
| T1 >T1 |
15 21 |
8 2 |
5.6 | (1.04,30.2) | 0.045 |
| C PTC Other PTC |
23 13 |
6 4 |
0.85 | (0.20,3.57) | 0.822 |
| (+) ETE (−) ETE |
14 22 |
0 10 |
0.36 | (0.00,0.69) | 0.004 |
| (+) LVI (−) LVI |
11 25 |
0 10 |
0.5 | (0.00,0.76) | 0.004 |
| T1, T2 T3, T4 |
18 18 |
9 1 |
9 | (1.03,78.6) | 0.047 |